Vivos Therapeutics (VVOS) Goodwill & Intangibles (2019 - 2026)

Vivos Therapeutics (VVOS) has 8 years of Goodwill & Intangibles data on file, last reported at $12.4 million in Q1 2026.

• Quarterly Goodwill & Intangibles rose 287.72% year-over-year to $12.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.4 million (up 287.72% YoY) and the FY2025 annual result came in at $12.6 million, up 293.18% from the prior year.
• Goodwill & Intangibles slipped to $12.4 million in Q1 2026 per VVOS's latest filing, from $12.6 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $12.6 million in Q4 2025 and bottomed at $3.1 million in Q4 2022.
• The 5-year median for Goodwill & Intangibles is $3.2 million (2023), against an average of $5.2 million.
• The widest annual swing landed in 2024, when Goodwill & Intangibles fell 2.82%; it then jumped 293.18% in 2025.
• Tracing VVOS's Goodwill & Intangibles over 5 years: stood at $3.1 million in 2022, then grew by 3.8% to $3.2 million in 2023, then declined by 0.34% to $3.2 million in 2024, then jumped by 293.18% to $12.6 million in 2025, then slipped by 1.63% to $12.4 million in 2026.
• Per Business Quant, the three latest VVOS Goodwill & Intangibles figures stand at $12.4 million (Q1 2026), $12.6 million (Q4 2025), and $10.6 million (Q3 2025).

Peer Comparison